Tudor Investment Corp’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-82,089
| Closed | -$3.33M | – | 3711 |
|
|
2025
Q4 | $3.33M | Sell |
82,089
-42,855
| -34% | -$1.86M | 0.01% | 1431 |
|
|
2025
Q3 | $5.88M | Buy |
124,944
+83,418
| +201% | +$4.32M | 0.01% | 1085 |
|
|
2025
Q2 | $2.16M | Buy |
+41,526
| New | +$2.28M | ﹤0.01% | 1612 |
|
|
2024
Q4 | – | Sell |
-49,285
| Closed | -$3.54M | – | 3075 |
|
|
2024
Q3 | $3.54M | Sell |
49,285
-59,036
| -55% | -$4.17M | 0.01% | 888 |
|
|
2024
Q2 | $7.51M | Sell |
108,321
-5,110
| -5% | -$373K | 0.04% | 489 |
|
|
2024
Q1 | $9.08M | Buy |
113,431
+36,187
| +47% | +$3.23M | 0.06% | 389 |
|
|
2023
Q4 | $8.46M | Sell |
77,244
-1,182
| -2% | -$122K | 0.07% | 402 |
|
|
2023
Q3 | $7.91M | Buy |
78,426
+62,677
| +398% | +$7.2M | 0.08% | 315 |
|
|
2023
Q2 | $2.14M | Sell |
15,749
-48,726
| -76% | -$5.95M | 0.03% | 864 |
|
|
2023
Q1 | $6.7M | Buy |
64,475
+11,274
| +21% | +$1.09M | 0.1% | 257 |
|
|
2022
Q4 | $4.72M | Sell |
53,201
-28,573
| -35% | -$2.37M | 0.09% | 271 |
|
|
2022
Q3 | $6.56M | Buy |
81,774
+8,944
| +12% | +$844K | 0.14% | 150 |
|
|
2022
Q2 | $6.97M | Buy |
72,830
+47,650
| +189% | +$5.72M | 0.18% | 107 |
|
|
2022
Q1 | $3.74M | Buy |
+25,180
| New | +$3.52M | 0.09% | 286 |
|
|
2020
Q4 | – | Sell |
-4,511
| Closed | -$355K | – | 1367 |
|
|
2020
Q3 | $355K | Sell |
4,511
-12,351
| -73% | -$1.01M | 0.02% | 935 |
|
|
2020
Q2 | $1.21M | Sell |
16,862
-7,650
| -31% | -$532K | 0.06% | 419 |
|
|
2020
Q1 | $1.4M | Buy |
24,512
+14,432
| +143% | +$1.33M | 0.13% | 164 |
|
|
2019
Q4 | $1.13M | Buy |
10,080
+4,721
| +88% | +$503K | 0.05% | 462 |
|
|
2019
Q3 | $515K | Buy |
+5,359
| New | +$503K | 0.02% | 702 |
|
|
2016
Q1 | – | Sell |
-5,000
| Closed | -$220K | – | 1773 |
|
|
2015
Q4 | $220K | Sell |
5,000
-1,500
| -23% | -$65.1K | 0.01% | 1402 |
|
|
2015
Q3 | $310K | Buy |
+6,500
| New | +$357K | 0.01% | 1084 |
|
|
2015
Q1 | – | Sell |
-8,180
| Closed | -$368K | – | 1466 |
|
|
2014
Q4 | $368K | Sell |
8,180
-16,462
| -67% | -$690K | 0.01% | 921 |
|
|
2014
Q3 | $908K | Buy |
24,642
+2,272
| +10% | +$90.1K | 0.03% | 336 |
|
|
2014
Q2 | $988K | Sell |
22,370
-2,553
| -10% | -$116K | 0.04% | 210 |
|
|
2014
Q1 | $1.08M | Buy |
24,923
+17,623
| +241% | +$785K | 0.05% | 179 |
|
|
2013
Q4 | $310K | Sell |
7,300
-3,800
| -34% | -$144K | 0.02% | 869 |
|
|
2013
Q3 | $377K | Sell |
11,100
-16,700
| -60% | -$545K | 0.02% | 478 |
|
|
2013
Q2 | $868K | Buy |
+27,800
| New | +$902K | 0.07% | 146 |
|
Other funds holding CNMD
VPM
VCM
CB
Tudor Investment Corp's CNMD Position: Q1 2026 in Review
Tudor Investment Corp sold out of CONMED (CNMD) in Q1 2026, closing a stake of 82,089 shares — an estimated $3.33M sold.
Tudor Investment Corp first reported a position in CNMD in Q2 2013 and held it in 28 quarters. The position peaked at $9.08M in Q1 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Tudor Investment Corp reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
- Tudor Investment Corp sold 82,089 CONMED shares in Q1 2026, an estimated $3.33M.
- Tudor Investment Corp first reported a position in CONMED in Q2 2013 and held it in 28 quarters.
- Tudor Investment Corp's CONMED position peaked at $9.08M in Q1 2024.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.